Seminars in Hematology
Volume 42, Issue 4 , Pages 266-273 , October 2005

Lessons From Familial Myeloproliferative Disorders

  • Radek Skoda

      Affiliations

    • Department of Research, Experimental Hematology, University of Basel, Basel, Switzerland.
    • Corresponding Author InformationAddress correspondence to Radek Skoda, MD, Department of Research, Experimental Hematology, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
    • ,
  • Josef T. Prchal

      Affiliations

    • Baylor College of Medicine, Houston, TX, USA.
    • Department of Pathophysiology, Charles University School of Medicine, Prague, Czech Republic.

References 

  1. Prchal JT , Crist WM , Goldwasser E , Perrine G , Prchal JF . Autosomal dominant polycythemia . Blood . 1985;66:1208–1214
  2. Emanuel PD , Eaves CJ , Broudy VC , Papayannopoulou T , Moore MR , D’Andrea AD , et al.   Familial and congenital polycythemia in three unrelated families . Blood . 1992;79:3019–3030
  3. Fisher MJ , Prchal JF , Prchal JT , D’Andrea AD . Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera . Blood . 1994;84:1982–1991
  4. Liu E , Jelinek J , Pastore YD , Guan Y , Prchal JF , Prchal JT . Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin . Blood . 2003;101:3294–3301
  5. Prchal JT . Polycythemia vera and other primary polycythemias . Curr Opin Hematol . 2005;12:112–116
  6. Sokol L , Luhovy M , Guan Y , Prchal JF , Semenza GL , Prchal JT . Primary familial polycythemia (A frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin) . Blood . 1995;86:15–22
  7. Juvonen E , Ikkala E , Fyhrquist F , Ruutu T . Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin . Blood . 1991;78:3066–3069
  8. Kralovics R , Indrak K , Stopka T , Berman BW , Prchal JF , Prchal JT . Two new EPO receptor mutations (Truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias) . Blood . 1997;90:2057–2061
  9. Kralovics R , Prchal JT . Genetic heterogeneity of primary familial and congenital polycythemia . Am J Hematol . 2001;68:115–121
  10. Kralovics R , Sokol L , Prchal JT . Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia . J Clin Invest . 1998;102:124–129
  11. Arcasoy MO , Jiang X , Haroon ZA . Expression of erythropoietin receptor splice variants in human cancer . Biochem Biophys Res Commun . 2003;307:999–1007
  12. Hess G , Rose P , Gamm H , Papadileris S , Huber C , Seliger B . Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera . Br J Haematol . 1994;88:794–802
  13. Le Couedic JP , Mitjavila MT , Villeval JL , et al.   Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies . Blood . 1996;87:1502–1511
  14. Kralovics R , Sokol L , Broxson EH , Prchal JT . The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia . Proc Assoc Am Physicians . 1997;109:580–585
  15. Sokol L , Prchal J , Prchal JT . Primary familial and congenital polycythaemia is a heterogeneous disorder . Lancet . 1993;342:115–116 (letter)
  16. Gordeuk V , Prchal JT . Serum erythropoietin and diagnosis of polycythemic states (Response to Dr. Van Maerken) . Haematologica . 2005; ELT(05), (e-letter)
  17. Gordeuk VR , Stockton DW , Prchal JT . Congenital polycythemias/erythrocytoses . Haematologica . 2005;90:109–116
  18. de la Chapelle A , Träskelin AL , Juvonen E . Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis . Proc Natl Acad Sci USA . 1993;90:4495–4499
  19. Percy MJ , McMullin MF , Roques AW , et al.   Erythrocytosis due to a mutation in the erythropoietin receptor gene . Br J Haematol . 1998;100:407–410
  20. Furukawa T , Narita M , Sakaue M , et al.   Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor . Br J Haematol . 1997;99:222–227
  21. Arcasoy MO , Degar BA , Harris KW , Forget BG . Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene . Blood . 1997;89:4628–4635
  22. Watowich SS , Xie X , Klingmuller U , et al.   Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state . Blood . 1999;94:2530–2532
  23. Wiestner A , Schlemper RJ , van der Maas AP , Skoda RC . An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia . Nature Genet . 1998;18:49–52
  24. Kondo T , Okabe M , Sanada M , et al.   Familial essential thrombocythemia associated with one-base deletion in the 5′-untranslated region of the thrombopoietin gene . Blood . 1998;92:1091–1096
  25. Ghilardi N , Skoda RC . A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocytosis through a mechanism of more efficient translation of TPO mRNA . Blood . 1999;94:1480–1482 (letter)
  26. Ghilardi N , Wiestner A , Kikuchi M , Oshaka A , Skoda RC . Hereditary thrombocythemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene . Br J Haematol . 1999;107:310–316
  27. Jorgensen MJ , Raskind WH , Wolff JF , Bachrach HR , Kaushansky K . Familial thrombocytosis associated with overproduction of thrombopoietin due to a novel splice donor site mutation . Blood . 1998;92:205a; (suppl 1, abstr)
  28. Cazzola M , Skoda RC . Translational pathophysiology (A novel molecular mechanism of human disease) . Blood . 2000;95:3280–3288
  29. Harrison CN , Gale RE , Wiestner AC , Skoda RC , Linch DC . The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia . Br J Haematol . 1998;102:1341–1343
  30. Komatsu H , Ding J , Iida M , et al.   Familial essentian thrombocythemia associated with a dominant positive acting mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin . Blood . 2003;102:198–200
  31. Onishi M , Mui ALF , Morikawa Y , et al.   Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer . Blood . 1996;88:1399–1406
  32. Kitamura T , Onishi M , Yahata T , Kanakura Y , Asano S . Activating mutations of the transmembrane domain of MPL in vitro and in vivo (Incorrect sequence of MPL-K, an alternative spliced form of MPL) . Blood . 1998;92:2596–2597 (letter)
  33. Kunishima S , Mizuno S , Naoe T , Saito H , Kamiya T . Genes for thrombopoietin and c-mpl are not responsible for familial thrombocythaemia (A case study) . Br J Haematol . 1998;100:383–386
  34. Wiestner A , Padosch SA , Ghilardi N , et al.   Hereditary thrombocythaemia is a genetically heterogeneous disorder (exclusion of TPO and MPL in two families with hereditary thrombocythaemia) . Br J Haematol . 2000;110:104–109
  35. Taksin AL , Couedic JP , Dusanter-Fourt I , et al.   Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L . Blood . 1999;93:125–139
  36. Fickers M , Speck B . Thrombocythaemia (Familial occurrence and transition into blastic crisis) . Acta Haematol . 1974;51:257–265
  37. Slee PHTJ , van Everdingen JJE , Geraedts JPM , te Velde J , den Ottolander GJ . Familial myeloproliferative disease . Acta Med Scand . 1981;210:321–327
  38. Eyster ME , Saletan SL , Rabellino EM , et al.   Familial essential thrombocythemia . Am J Med . 1986;80:497–502
  39. Ulibarrena C , Vecino AM , Odriozola J , Cesar JM . Familial essential thrombocythemia associated with von Willebrand disease . Med Clin (Barc) . 1997;109:237; (letter)
  40. Williams EC , Shahidi NT . Benign familial thrombocytosis . Am J Hematol . 1991;37:124–125
  41. Cohen N , Almoznino-Sarafian D , Weissgarten J , et al.   Benign familial microcytic thrombocytosis with autosomal dominant transmission . Clin Genet . 1997;52:47–50
  42. Carrel L , Willard HF . X-inactivation profile reveals extensive variability in X-linked gene expression in females . Nature . 2005;434:400–404
  43. Beutler E , Yeh M , Fairbanks VF . The normal human female as a mosaic of X-chromosome activity (Studies using the gene for C-6-PD-deficiency as a marker) . Proc Natl Acad Sci USA . 1962;48:9–16
  44. Vogelstein B , Fearon ER , Hamilton SR , Feinberg AP . Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors . Science . 1985;227:642–645
  45. Fearon ER , Winkelstein JA , Civin CI , Pardoll DM , Vogelstein B . Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation . N Engl J Med . 1987;316:427–431
  46. Abrahamson G , Fraser NJ , Boyd J , Craig I , Wainscoat JS . A highly informative X-chromosome probe, M27 beta, can be used for the determination of tumour clonality . Br J Haematol . 1990;74:371–372
  47. Gilliland DG , Blanchard KL , Levy J , Perrin S , Bunn HF . Clonality in myeloproliferative disorders (Analysis by means of the polymerase chain reaction) . Proc Natl Acad Sci USA . 1991;88:6848–6852
  48. Curnutte JT , Hopkins PJ , Kuhl W , Beutler E . Studying X inactivation . Lancet . 1992;339:749; (letter)
  49. Prchal JT , Guan YL , Prchal JF , Barany F . Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis . Blood . 1993;81:269–271 (letter)
  50. Luhovy M , Liu Y , Belickova M , Prchal JF , Prchal JT . A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55 . Biol Blood Marrow Transplant . 1995;1:81–87
  51. Gregg XT , Kralovics R , Prchal JT . A polymorphism of the X-linked gene IDS increases the number of females informative for transcriptional clonality assays . Am J Hematol . 2000;63:184–191
  52. Kralovics R , Guan Y , Prchal JT . Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera . Exp Hematol . 2002;30:229–236
  53. Prchal JF , Axelrad AA . Bone-marrow responses in polycythemia vera . N Engl J Med . 1974;290:1382; (letter)
  54. Ang SO , Chen H , Gordeuk VR , et al.   Endemic polycythemia in Russia (Mutation in the VHL gene) . Blood Cells Mol Dis . 2002;28:57–62
  55. Weinberg RS , Worsley A , Gilbert HS , Cuttner J , Berk PD , Alter BP . Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia (Only polycythemia vera has endogenous colonies) . Leuk Res . 1989;13:331–338
  56. Weinberg RS . In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders . Semin Hematol . 1997;34:64–69
  57. Eaves CJ , Eaves AC . Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera . Blood . 1978;52:1196–1210
  58. Cashman J , Henkelman D , Humphries K , Eaves C , Eaves A . Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny . Blood . 1983;61:876–884
  59. Kralovics R , Buser AS , Teo SS , et al.   Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders . Blood . 2003;102:1869–1871
  60. James C , Ugo V , Le Couedic JP , et al.   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera . Nature . 2005;434:1144–1148
  61. Levine RL , Wadleigh M , Cools J , et al.   Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis . Cancer Cell . 2005;7:387–397
  62. Kralovics R , Passamonti F , Buser AS , et al.   A gain-of-function mutation of JAK2 in myeloproliferative disorders . N Engl J Med . 2005;352:1779–1790
  63. Baxter EJ , Scott LM , Campbell PJ , et al.   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders . Lancet . 2005;365:1054–1061
  64. Prchal JT . Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders . Semin Hematol . 2001;38:10–20
  65. Ratnoff WD , Gress RE . The familial occurrence of polycythemia vera (Report of a father and son, with consideration of the possible etiologic role of exposure to organic solvents, including tetrachloroethylene) . Blood . 1980;56:233–236
  66. Friedland ML , Wittels EG , Robinson RJ . Polycythemia vera in identical twins . Am J Hematol . 1981;10:101–103
  67. Inaba T , Shimazaki C , Hirai H , et al.   Familial polycythemia vera in father and daughter . Am J Hematol . 1996;51:172; (letter)
  68. Kralovics R , Stockton DW , Prchal JT . Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease . Blood . 2003;102:3793–3797
  69. Prchal JT , Prchal JF , Belickova M , et al.   Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism . J Exp Med . 1996;183:561–567
  70. Zhao R , Xing S , Li Z , et al.   Identification of an acquired JAK2 mutation in polycythemia vera . J Biol Chem . 2005;280:22788–22792
  71. Jones AV , Kreil S , Zoi K , et al.   Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders . Blood . 2005; [Epub ahead of print]
  72. Steensma DP , Dewald GW , Lasho TL , et al.   The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and the myelodysplastic syndrome . Blood . 2005;106:1207–1209
  73. Gregg XT , Prchal JT . Erythropoietin receptor mutations and human disease . Semin Hematol . 1997;34:70–76
  74. Phelan JT , Prchal JT . Clonality studies in cancer based on X chromosome inactivation phenomenon . Methods Mol Med . 2002;68:251–270
  75. Najfeld V , Montella L , Scalise A , Fruchtman S . Exploring polycythaemia vera with fluorescence in situ hybridization (additional cryptic 9p is the most frequent abnormality detected) . Br J Haematol . 2002;119:558–566
  76. Abel L , Alcais A , Mallet A . Comparison of four sib-pair linkage methods for analyzing sibships with more than two affecteds (Interest of the binomial maximum likelihood approach) . Genet Epidemiol . 1998;15:371–390
  77. Knapp M . Using exact P values to compare the power between the reconstruction-combined transmission/disequilibrium test and the sib transmission/disequilibrium test . Am J Hum Genet . 1999;65:1208–1210
  78. Lo SH , Liu X , Shao Y . A marginal likelihood model for family-based data . Ann Hum Genet . 2003;67:357–366
  79. Rabinowitz D . Adjusting for population heterogeneity (A framework for characterizing statistical information and developing efficient test statistics) . Genet Epidemiol . 2003;24:284–290
  80. Perez-Encinas M , Bello JL , Campos A , De Miguel R , Tome S . Familial myeloproliferative syndrome . Am J Hematol . 1994;46:225–229
  81. Najman A , Chaumarel I , Bellanne-Chantelot C , et al.   Phenotypic description of familial chronic myeloproliferative disorders . Blood . 2004;104:190a; (abstr)

PII: S0037-1963(05)00144-7

doi: 10.1053/j.seminhematol.2005.08.002

Seminars in Hematology
Volume 42, Issue 4 , Pages 266-273 , October 2005

Article Tools

* Image Usage & Resolution